ADME Study in Healthy Male Subjects With TA-8995

• Status: Completed
• Trial end date: 2015-08-01
• Target enrollment: 0
• Participant gender: Male

Summary

A study to measure the absorption, metabolism and excretion of a single dose of radiolabelled TA-8995 (10mg) in healthy male subjects.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Xention Ltd

Criteria

Inclusion Criteria:

• Healthy male subjects

Exclusion Criteria:

• Clinically significant abnormalities